Drug-eluting balloon new option for "untreatable" and high-risk PCI patients
This article was originally published in Clinica
Executive Summary
A next-generation drug-eluting coronary balloon dilatation catheter could provide a new option for high-risk patients requiring percutaneous coronary intervention (PCI). It could treat patients immediately after they have suffered a heart attack, and could also be of benefit in patients with diabetes and renal disease.